Codiak BioSciences Obtains $80,000,000 Series A Financing Round

  • Feed Type
  • Date
    11/18/2015
  • Company Name
    Codiak BioSciences
  • Mailing Address
    Undisclosed Seattle, WA 94117 USA
  • Company Description
    Codiak Biosciences, Inc. develops exosome technology for cancer diagnoses.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $80,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Fidelity Management & Research Company
  • Venture Investor
    Alaska Permanent Fund
  • Venture Investor
    Alexandria Venture Investments